Advanced search
Publication Cover
Acta Oncologica Volume 59, 2020 - Issue 1
Journal homepage
2,214
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: MEDICAL ONCOLOGY

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry

X. G. L. V. PouwelsDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands; ;Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; ;School of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0003-3563-0013View further author information
ORCID Icon,
S. M. E. GeurtsSchool of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; ;Division Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands; ORCID Iconhttp://orcid.org/0000-0002-4265-9968View further author information
ORCID Icon,
B. L. T. RamaekersDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands; View further author information
,
F. ErdkampDepartment of Internal Medicine, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands; View further author information
,
B. E. P. J. VriensDepartment of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands; View further author information
,
K. N. A. AalderingDepartment of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands; View further author information
,
A. J. van de WouwDepartment of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands; View further author information
,
M. W. DercksenDepartment of Internal Medicine, Máxima Medical Centre, Veldhoven/Eindhoven, The Netherlands; View further author information
,
T. J. SmildeDepartment of Internal Medicine, Jeroen Bosch Hospital, Hertogenbosch, The Netherlands; View further author information
,
N. A. J. B. PetersDepartment of Internal Medicine, Sint Jans Gasthuis, Weert, The Netherlands; View further author information
,
J. M. van RielDepartment of Internal Medicine, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands; View further author information
,
M. J. PepelsDepartment of Internal Medicine, Elkerliek Hospital, Helmond, The NetherlandsView further author information
,
J. Heijnen-MommersSchool of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; ;Division Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands; View further author information
,
M. A. JooreDepartment of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands; ;Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; View further author information
,
V. C. G. Tjan-HeijnenSchool of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; ;Division Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands; View further author information
&
M. de BoerSchool of Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands; ;Division Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands; Correspondence[email protected]
View further author information
 show all
Pages 82-89 | Received 16 Jul 2019, Accepted 16 Sep 2019, Published online: 04 Oct 2019

Related Research Data

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry
Source: Taylor & Francis
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry
Source: Taylor & Francis
The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.